annual FCF:
$289.00M+$70.74M(+32.41%)Summary
- As of today (August 16, 2025), BIO annual free cash flow is $289.00 million, with the most recent change of +$70.74 million (+32.41%) on December 31, 2024.
- During the last 3 years, BIO annual FCF has risen by +$838.18 million (+152.62%).
- BIO annual FCF is now -78.14% below its all-time high of $1.32 billion, reached on December 31, 2022.
Performance
BIO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$70.80M-$24.70M(-25.86%)Summary
- As of today (August 16, 2025), BIO quarterly free cash flow is $70.80 million, with the most recent change of -$24.70 million (-25.86%) on June 30, 2025.
- Over the past year, BIO quarterly FCF has increased by +$15.50 million (+28.03%).
- BIO quarterly FCF is now -71.17% below its all-time high of $245.60 million, reached on December 31, 2020.
Performance
BIO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$347.60M+$15.50M(+4.67%)Summary
- As of today (August 16, 2025), BIO TTM free cash flow is $347.60 million, with the most recent change of +$15.50 million (+4.67%) on June 30, 2025.
- Over the past year, BIO TTM FCF has increased by +$170.32 million (+96.08%).
- BIO TTM FCF is now -47.86% below its all-time high of $666.63 million, reached on September 30, 2021.
Performance
BIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BIO Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.4% | +28.0% | +96.1% |
| 3 y3 years | +152.6% | +97.0% | -4.5% |
| 5 y5 years | -19.6% | -4.3% | +8.0% |
BIO Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.1% | +152.6% | -29.2% | +527.9% | -4.5% | +334.0% |
| 5 y | 5-year | -78.1% | +152.6% | -71.2% | +527.9% | -47.9% | +334.0% |
| alltime | all time | -78.1% | +152.6% | -71.2% | +137.7% | -47.9% | +277.3% |
BIO Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $70.80M(-25.9%) | $347.60M(+4.7%) |
| Mar 2025 | - | $95.50M(+17.5%) | $332.10M(+24.8%) |
| Dec 2024 | $289.00M(+32.4%) | $81.25M(-18.8%) | $266.20M(+19.0%) |
| Sep 2024 | - | $100.05M(+80.9%) | $223.69M(+26.2%) |
| Jun 2024 | - | $55.30M(+86.8%) | $177.28M(-4.4%) |
| Mar 2024 | - | $29.60M(-23.6%) | $185.41M(-15.0%) |
| Dec 2023 | $218.26M(-83.5%) | $38.74M(-27.8%) | $218.20M(-2.0%) |
| Sep 2023 | - | $53.64M(-15.4%) | $222.76M(+46.0%) |
| Jun 2023 | - | $63.43M(+1.7%) | $152.57M(+22.0%) |
| Mar 2023 | - | $62.39M(+44.1%) | $125.08M(+56.2%) |
| Dec 2022 | $1.32B(-340.7%) | $43.30M(-361.6%) | $80.10M(-47.1%) |
| Sep 2022 | - | -$16.55M(-146.0%) | $151.49M(-58.4%) |
| Jun 2022 | - | $35.94M(+106.3%) | $363.77M(-20.8%) |
| Mar 2022 | - | $17.42M(-84.8%) | $459.07M(-14.3%) |
| Dec 2021 | -$549.18M(-215.3%) | $114.68M(-41.4%) | $535.72M(-19.6%) |
| Sep 2021 | - | $195.74M(+49.1%) | $666.63M(+13.6%) |
| Jun 2021 | - | $131.24M(+39.5%) | $586.58M(+10.8%) |
| Mar 2021 | - | $94.06M(-61.7%) | $529.35M(+11.1%) |
| Dec 2020 | $476.41M(+32.6%) | $245.60M(+112.3%) | $476.41M(+29.1%) |
| Sep 2020 | - | $115.69M(+56.3%) | $369.01M(+14.6%) |
| Jun 2020 | - | $74.01M(+80.0%) | $321.99M(-15.5%) |
| Mar 2020 | - | $41.12M(-70.2%) | $381.17M(+6.1%) |
| Dec 2019 | $359.37M(+130.9%) | $138.20M(+101.3%) | $359.37M(+32.0%) |
| Sep 2019 | - | $68.66M(-48.4%) | $272.30M(+11.7%) |
| Jun 2019 | - | $133.19M(+589.6%) | $243.86M(+50.7%) |
| Mar 2019 | - | $19.31M(-62.2%) | $161.82M(+4.0%) |
| Dec 2018 | $155.67M(-1516.4%) | $51.13M(+27.1%) | $155.67M(+5.3%) |
| Sep 2018 | - | $40.22M(-21.4%) | $147.82M(+27.6%) |
| Jun 2018 | - | $51.15M(+288.6%) | $115.89M(+18.6%) |
| Mar 2018 | - | $13.16M(-69.6%) | $97.71M(-989.1%) |
| Dec 2017 | -$10.99M(-114.7%) | $43.29M(+422.1%) | -$10.99M(+130.3%) |
| Sep 2017 | - | $8.29M(-74.8%) | -$4.77M(+421.5%) |
| Jun 2017 | - | $32.96M(-134.5%) | -$915.00K(-107.8%) |
| Mar 2017 | - | -$95.53M(-293.0%) | $11.70M(-84.3%) |
| Dec 2016 | $74.86M(+2.8%) | $49.51M(+307.5%) | $74.50M(+126.1%) |
| Sep 2016 | - | $12.15M(-73.3%) | $32.95M(-57.9%) |
| Jun 2016 | - | $45.58M(-239.2%) | $78.28M(+100.6%) |
| Mar 2016 | - | -$32.74M(-510.9%) | $39.03M(-46.4%) |
| Dec 2015 | $72.84M(-46.8%) | $7.97M(-86.1%) | $72.84M(+12.1%) |
| Sep 2015 | - | $57.48M(+808.1%) | $64.96M(-8.1%) |
| Jun 2015 | - | $6.33M(+497.7%) | $70.67M(-34.1%) |
| Mar 2015 | - | $1.06M(+1063.7%) | $107.26M(-21.6%) |
| Dec 2014 | $136.83M(+121.5%) | $91.00K(-99.9%) | $136.83M(-23.7%) |
| Sep 2014 | - | $63.19M(+47.2%) | $179.37M(+19.0%) |
| Jun 2014 | - | $42.92M(+40.1%) | $150.67M(+46.3%) |
| Mar 2014 | - | $30.63M(-28.1%) | $102.96M(+66.7%) |
| Dec 2013 | $61.78M(-50.5%) | $42.63M(+23.6%) | $61.78M(-17.4%) |
| Sep 2013 | - | $34.49M(-819.3%) | $74.83M(+0.4%) |
| Jun 2013 | - | -$4.79M(-54.5%) | $74.52M(-32.8%) |
| Mar 2013 | - | -$10.55M(-118.9%) | $110.92M(-9.0%) |
| Dec 2012 | $124.70M(-20.3%) | $55.68M(+62.9%) | $121.83M(+8.8%) |
| Sep 2012 | - | $34.18M(+8.1%) | $112.00M(+7.7%) |
| Jun 2012 | - | $31.61M(+8656.5%) | $104.00M(-34.1%) |
| Mar 2012 | - | $361.00K(-99.2%) | $157.90M(-0.9%) |
| Dec 2011 | $156.49M(+16.3%) | $45.84M(+75.1%) | $159.41M(-11.6%) |
| Sep 2011 | - | $26.19M(-69.4%) | $180.40M(-9.8%) |
| Jun 2011 | - | $85.51M(+4472.8%) | $200.01M(+52.6%) |
| Mar 2011 | - | $1.87M(-97.2%) | $131.07M(-1.7%) |
| Dec 2010 | $134.56M(-45.9%) | $66.83M(+46.0%) | $133.38M(-17.8%) |
| Sep 2010 | - | $45.79M(+176.3%) | $162.26M(-17.4%) |
| Jun 2010 | - | $16.57M(+296.5%) | $196.35M(-26.0%) |
| Mar 2010 | - | $4.18M(-95.6%) | $265.19M(+6.6%) |
| Dec 2009 | $248.71M(+142.5%) | $95.72M(+19.8%) | $248.71M(+19.2%) |
| Sep 2009 | - | $79.88M(-6.5%) | $208.65M(+40.0%) |
| Jun 2009 | - | $85.40M(-794.6%) | $149.02M(+32.9%) |
| Mar 2009 | - | -$12.30M(-122.1%) | $112.16M(+9.4%) |
| Dec 2008 | $102.56M(-20.4%) | $55.66M(+174.9%) | $102.56M(-24.2%) |
| Sep 2008 | - | $20.25M(-58.3%) | $135.40M(-10.6%) |
| Jun 2008 | - | $48.55M(-321.7%) | $151.48M(+15.7%) |
| Mar 2008 | - | -$21.90M(-124.7%) | $130.97M(+1.6%) |
| Dec 2007 | $128.91M | $88.49M(+143.6%) | $128.91M(+60.4%) |
| Sep 2007 | - | $36.33M(+29.6%) | $80.37M(-2.8%) |
| Jun 2007 | - | $28.04M(-217.1%) | $82.69M(-12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$23.95M(-159.9%) | $94.68M(+45.1%) |
| Dec 2006 | $65.20M(-3.0%) | $39.95M(+3.4%) | $65.24M(+0.5%) |
| Sep 2006 | - | $38.65M(-3.5%) | $64.92M(+33.5%) |
| Jun 2006 | - | $40.03M(-175.0%) | $48.64M(+1203.8%) |
| Mar 2006 | - | -$53.39M(-234.7%) | $3.73M(-94.8%) |
| Dec 2005 | $67.23M(+27.8%) | $39.63M(+77.2%) | $72.23M(+11.5%) |
| Sep 2005 | - | $22.37M(-558.2%) | $64.76M(+19.2%) |
| Jun 2005 | - | -$4.88M(-132.3%) | $54.34M(-14.9%) |
| Mar 2005 | - | $15.11M(-53.0%) | $63.82M(+1.9%) |
| Dec 2004 | $52.60M(-10.3%) | $32.16M(+169.2%) | $62.60M(+32.7%) |
| Sep 2004 | - | $11.95M(+159.9%) | $47.18M(-15.6%) |
| Jun 2004 | - | $4.60M(-66.9%) | $55.90M(-9.5%) |
| Mar 2004 | - | $13.89M(-17.1%) | $61.79M(+5.4%) |
| Dec 2003 | $58.64M(-6.3%) | $16.74M(-19.0%) | $58.64M(-11.9%) |
| Sep 2003 | - | $20.67M(+97.1%) | $66.53M(+1.2%) |
| Jun 2003 | - | $10.48M(-2.4%) | $65.76M(+1.8%) |
| Mar 2003 | - | $10.74M(-56.4%) | $64.58M(+1.6%) |
| Dec 2002 | $62.60M(+11.2%) | $24.64M(+23.9%) | $63.53M(-6.8%) |
| Sep 2002 | - | $19.90M(+113.9%) | $68.15M(+17.7%) |
| Jun 2002 | - | $9.30M(-4.0%) | $57.91M(-20.7%) |
| Mar 2002 | - | $9.69M(-66.9%) | $73.02M(+29.8%) |
| Dec 2001 | $56.30M(-886.4%) | $29.25M(+202.7%) | $56.27M(+121.3%) |
| Sep 2001 | - | $9.66M(-60.4%) | $25.43M(+66.4%) |
| Jun 2001 | - | $24.41M(-445.6%) | $15.28M(<-9900.0%) |
| Mar 2001 | - | -$7.06M(+346.2%) | -$82.00K(-98.9%) |
| Dec 2000 | -$7.16M(-140.4%) | -$1.58M(+227.1%) | -$7.16M(-96.3%) |
| Sep 2000 | - | -$484.00K(-105.3%) | -$193.58M(+0.7%) |
| Jun 2000 | - | $9.05M(-164.0%) | -$192.29M(-1.9%) |
| Mar 2000 | - | -$14.14M(-92.5%) | -$196.04M(+5.9%) |
| Dec 1999 | $17.71M(+187.5%) | -$188.00M(<-9900.0%) | -$185.10M(-2568.0%) |
| Sep 1999 | - | $800.00K(-84.9%) | $7.50M(-16.7%) |
| Jun 1999 | - | $5.30M(-265.6%) | $9.00M(+25.0%) |
| Mar 1999 | - | -$3.20M(-169.6%) | $7.20M(+18.0%) |
| Dec 1998 | $6.16M(-350.2%) | $4.60M(+100.0%) | $6.10M(-118.7%) |
| Sep 1998 | - | $2.30M(-34.3%) | -$32.60M(+1.9%) |
| Jun 1998 | - | $3.50M(-181.4%) | -$32.00M(-1.5%) |
| Mar 1998 | - | -$4.30M(-87.4%) | -$32.50M(-3.6%) |
| Dec 1997 | -$2.46M(-113.7%) | -$34.10M(-1275.9%) | -$33.70M(-942.5%) |
| Sep 1997 | - | $2.90M(-3.3%) | $4.00M(-366.7%) |
| Jun 1997 | - | $3.00M(-154.5%) | -$1.50M(-122.4%) |
| Mar 1997 | - | -$5.50M(-252.8%) | $6.70M(-62.8%) |
| Dec 1996 | $17.92M(-30.9%) | $3.60M(-238.5%) | $18.00M(-30.8%) |
| Sep 1996 | - | -$2.60M(-123.2%) | $26.00M(-15.6%) |
| Jun 1996 | - | $11.20M(+93.1%) | $30.80M(+18.9%) |
| Mar 1996 | - | $5.80M(-50.0%) | $25.90M(0.0%) |
| Dec 1995 | $25.93M(-32.6%) | $11.60M(+427.3%) | $25.90M(+16.7%) |
| Sep 1995 | - | $2.20M(-65.1%) | $22.20M(-11.2%) |
| Jun 1995 | - | $6.30M(+8.6%) | $25.00M(-19.4%) |
| Mar 1995 | - | $5.80M(-26.6%) | $31.00M(-19.5%) |
| Dec 1994 | $38.48M(+382.3%) | $7.90M(+58.0%) | $38.50M(-20.0%) |
| Sep 1994 | - | $5.00M(-59.3%) | $48.10M(+5.9%) |
| Jun 1994 | - | $12.30M(-7.5%) | $45.40M(+63.9%) |
| Mar 1994 | - | $13.30M(-24.0%) | $27.70M(+246.3%) |
| Dec 1993 | $7.98M(-148.5%) | $17.50M(+660.9%) | $8.00M(-132.1%) |
| Sep 1993 | - | $2.30M(-142.6%) | -$24.90M(+70.5%) |
| Jun 1993 | - | -$5.40M(-15.6%) | -$14.60M(-8.2%) |
| Mar 1993 | - | -$6.40M(-58.4%) | -$15.90M(-3.0%) |
| Dec 1992 | -$16.46M(-38.6%) | -$15.40M(-222.2%) | -$16.40M(+613.0%) |
| Sep 1992 | - | $12.60M(-288.1%) | -$2.30M(-90.3%) |
| Jun 1992 | - | -$6.70M(-2.9%) | -$23.80M(-2.1%) |
| Mar 1992 | - | -$6.90M(+430.8%) | -$24.30M(-9.7%) |
| Dec 1991 | -$26.81M(+1919.1%) | -$1.30M(-85.4%) | -$26.90M(-3.9%) |
| Sep 1991 | - | -$8.90M(+23.6%) | -$28.00M(+60.0%) |
| Jun 1991 | - | -$7.20M(-24.2%) | -$17.50M(+34.6%) |
| Mar 1991 | - | -$9.50M(+295.8%) | -$13.00M(+900.0%) |
| Dec 1990 | -$1.33M(+150.6%) | -$2.40M(-250.0%) | -$1.30M(-218.2%) |
| Sep 1990 | - | $1.60M(-159.3%) | $1.10M(-320.0%) |
| Jun 1990 | - | -$2.70M(-222.7%) | -$500.00K(-122.7%) |
| Mar 1990 | - | $2.20M | $2.20M |
| Dec 1988 | -$530.00K(-97.4%) | - | - |
| Dec 1987 | -$20.30M(+18.0%) | - | - |
| Dec 1986 | -$17.20M(+257.4%) | - | - |
| Dec 1985 | -$4.81M(-76.2%) | - | - |
| Dec 1984 | -$20.27M | - | - |
FAQ
- What is Bio-Rad Laboratories, Inc. annual free cash flow?
- What is the all time high annual FCF for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. annual FCF year-on-year change?
- What is Bio-Rad Laboratories, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. quarterly FCF year-on-year change?
- What is Bio-Rad Laboratories, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Bio-Rad Laboratories, Inc.?
- What is Bio-Rad Laboratories, Inc. TTM FCF year-on-year change?
What is Bio-Rad Laboratories, Inc. annual free cash flow?
The current annual FCF of BIO is $289.00M
What is the all time high annual FCF for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high annual free cash flow is $1.32B
What is Bio-Rad Laboratories, Inc. annual FCF year-on-year change?
Over the past year, BIO annual free cash flow has changed by +$70.74M (+32.41%)
What is Bio-Rad Laboratories, Inc. quarterly free cash flow?
The current quarterly FCF of BIO is $70.80M
What is the all time high quarterly FCF for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high quarterly free cash flow is $245.60M
What is Bio-Rad Laboratories, Inc. quarterly FCF year-on-year change?
Over the past year, BIO quarterly free cash flow has changed by +$15.50M (+28.03%)
What is Bio-Rad Laboratories, Inc. TTM free cash flow?
The current TTM FCF of BIO is $347.60M
What is the all time high TTM FCF for Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. all-time high TTM free cash flow is $666.63M
What is Bio-Rad Laboratories, Inc. TTM FCF year-on-year change?
Over the past year, BIO TTM free cash flow has changed by +$170.32M (+96.08%)